COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 222.8 | 4 | 0003-0047 | 340.50 | 45.67 | 547 | 92.47 | 0.804 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 205.1 | 4 | 0004-0045 | 603.98 | 44.77 | 467 | 82.91 | 0.854 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 215.4 | 4 | 0005-0048 | 902.79 | 48.58 | 451 | 79.50 | 0.897 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 581.3 | 4 | 0006-0049 | 366.86 | 49.04 | 475 | 82.77 | 0.871 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 160.9 | 4 | 0007-0053 | 759.08 | 52.52 | 483 | 88.67 | 0.772 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 269.4 | 4 | 0008-0055 | 249.77 | 55.49 | 442 | 78.43 | 0.903 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 198.0 | 4 | 0009-0056 | 945.82 | 56.49 | 406 | 75.26 | 0.901 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 264.0 | 4 | 0010-0056 | 99.02 | 56.17 | 435 | 83.50 | 0.784 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 241.1 | 4 | 0011-0061 | 322.34 | 62.53 | 456 | 81.98 | 0.853 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 276.7 | 4 | 0012-0064 | 75.47 | 64.64 | 501 | 87.94 | 0.814 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 225.8 | 4 | 0013-0066 | 620.14 | 67.05 | 499 | 85.98 | 0.848 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 310.5 | 4 | 0014-0071 | 446.82 | 70.23 | 938 | 125.44 | 0.749 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 207.4 | 4 | 0015-0073 | 669.51 | 73.09 | 432 | 76.43 | 0.929 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 205.8 | 4 | 0016-0077 | 835.66 | 77.03 | 516 | 88.71 | 0.824 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 266.8 | 4 | 0017-0077 | 744.64 | 78.29 | 438 | 80.43 | 0.851 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 229.3 | 4 | 0018-0080 | 545.97 | 80.59 | 922 | 121.30 | 0.787 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.7 | 4 | 0019-0086 | 80.39 | 85.76 | 433 | 82.08 | 0.808 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 295.7 | 4 | 0020-0090 | 179.51 | 90.53 | 727 | 103.64 | 0.851 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 213.2 | 4 | 0021-0096 | 849.52 | 96.88 | 428 | 81.15 | 0.817 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 268.0 | 4 | 0022-0097 | 118.83 | 97.58 | 763 | 103.40 | 0.897 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.4 | 4 | 0023-0100 | 519.10 | 99.71 | 481 | 85.74 | 0.822 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 234.4 | 4 | 0024-0100 | 348.91 | 100.90 | 383 | 75.50 | 0.844 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 188.4 | 4 | 0025-0102 | 889.05 | 102.48 | 431 | 77.26 | 0.907 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 249.5 | 4 | 0026-0105 | 706.22 | 105.50 | 424 | 76.67 | 0.906 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 266.6 | 4 | 0027-0114 | 78.30 | 115.10 | 429 | 85.26 | 0.742 |